SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-19-005695
Filing Date
2019-06-14
Accepted
2019-06-14 07:50:29
Documents
2
Effectiveness Date
2019-06-14

Document Format Files

Seq Description Document Type Size
1 nviv-20190614xdefa14a.htm DEFA14A 65088
2 nviv20190614xdefa14a001.jpg GRAPHIC 5107
  Complete submission text file 0001558370-19-005695.txt   73446
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37350 | Film No.: 19897589
SIC: 3841 Surgical & Medical Instruments & Apparatus